BANK OF MONTREAL /CAN/ - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 44 filers reported holding REPROS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$1,0001,0000.0%0.00%
Q3 2017$01,0000.0%0.00%
Q2 2017$0
-100.0%
1,0000.0%0.00%
Q1 2017$1,000
-50.0%
1,0000.0%0.00%
Q4 2016$2,0000.0%1,0000.0%0.00%
Q3 2016$2,0000.0%1,0000.0%0.00%
Q2 2016$2,000
+100.0%
1,0000.0%0.00%
Q1 2016$1,0000.0%1,0000.0%0.00%
Q4 2015$1,000
-88.9%
1,000
-20.0%
0.00%
Q3 2015$9,000
+28.6%
1,250
+25.0%
0.00%
Q2 2015$7,000
-22.2%
1,0000.0%0.00%
Q1 2015$9,000
-98.4%
1,000
-98.3%
0.00%
-100.0%
Q4 2014$580,000
-18.7%
58,201
-19.2%
0.00%0.0%
Q3 2014$713,000
-39.7%
72,000
+5.3%
0.00%0.0%
Q2 2014$1,183,000
-49.5%
68,370
-48.3%
0.00%
-66.7%
Q1 2014$2,344,000
+941.8%
132,125
+974.2%
0.00%
Q4 2013$225,000
-49.8%
12,300
-26.3%
0.00%
Q3 2013$448,000
+2388.9%
16,700
+1570.0%
0.00%
Q2 2013$18,0001,0000.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,132,367$11,210,0004.33%
DESTRIER CAPITAL MANAGEMENT LLC 933,600$9,243,0002.32%
SENZAR ASSET MANAGEMENT, LLC 753,600$7,460,0002.19%
ORACLE INVESTMENT MANAGEMENT INC 1,014,164$10,040,0001.39%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 775,307$7,675,0000.50%
Trellus Management Company, LLC 50,000$495,0000.42%
FNY Managed Accounts LLC 14,000$138,600,0000.42%
GENERAL AMERICAN INVESTORS CO INC 449,475$4,450,0000.36%
Baker Brothers Advisors 2,778,654$27,509,0000.35%
CQS Cayman LP 550,000$5,445,0000.32%
View complete list of REPROS THERAPEUTICS INC shareholders